BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18758476)

  • 1. It's T-ALL about Notch.
    Demarest RM; Ratti F; Capobianco AJ
    Oncogene; 2008 Sep; 27(38):5082-91. PubMed ID: 18758476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells.
    Geimer Le Lay AS; Oravecz A; Mastio J; Jung C; Marchal P; Ebel C; Dembélé D; Jost B; Le Gras S; Thibault C; Borggrefe T; Kastner P; Chan S
    Sci Signal; 2014 Mar; 7(317):ra28. PubMed ID: 24643801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
    Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
    Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ikaros regulates Notch target gene expression in developing thymocytes.
    Chari S; Winandy S
    J Immunol; 2008 Nov; 181(9):6265-74. PubMed ID: 18941217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
    Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
    Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7.
    Ishikawa Y; Onoyama I; Nakayama KI; Nakayama K
    Oncogene; 2008 Oct; 27(47):6164-74. PubMed ID: 18641686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
    Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
    Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models in tumor suppression.
    Ghebranious N; Donehower LA
    Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of T cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Ferrando A
    J Clin Invest; 2012 Oct; 122(10):3398-406. PubMed ID: 23023710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch and Ikaros: not only converging players in T cell leukemia.
    Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Gulino A; Screpanti I
    Cell Cycle; 2007 Nov; 6(22):2730-4. PubMed ID: 18032925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.
    Kaveri D; Kastner P; Dembélé D; Nerlov C; Chan S; Kirstetter P
    Blood; 2013 Aug; 122(5):694-704. PubMed ID: 23801632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost.
    Beverly LJ; Capobianco AJ
    Trends Mol Med; 2004 Dec; 10(12):591-8. PubMed ID: 15567329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia.
    Staal FJ; Langerak AW
    Haematologica; 2008 Apr; 93(4):493-7. PubMed ID: 18379008
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.
    Beverly LJ; Felsher DW; Capobianco AJ
    Cancer Res; 2005 Aug; 65(16):7159-68. PubMed ID: 16103066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell cycle regulation by F-box protein Fbxw7].
    Tsunematsu R
    Fukuoka Igaku Zasshi; 2009 Apr; 100(4):87-94. PubMed ID: 19562935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.